How do occupational doctors handle PMDD in the workplace
Official title: Occupational Physicians Facing Premenstrual Dysphoric Disorder: Knowledge, Perceptions and Practices in Occupational Health
Run by University Hospital, Strasbourg, France · NCT07864285 · Data updated 2026-11-12
This study tests what French occupational physicians know and how they think about PMDD and how they manage it in the workplace.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 15 (estimated) |
| Sponsor | University Hospital, Strasbourg, France Academic / other |
| Locations | 1 site (Strasbourg) |
| Status | Recruiting |
| Started | March 9, 2026 |
| Main results expected | December 9, 2026 |
| Study ends | March 9, 2027 |
| Registry record updated | October 7, 2026 |
| Trial ID | NCT07864285 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are French- practicing occupational physicians or occupational health collaborators with at least two years of experience and fluency in French.
✕Probably not a fit
Participants not involved in PMDD care or without an interest in occupational health may derive no direct personal benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study surveys occupational physicians and occupational health collaborators in France to understand their knowledge, perceptions, and practices related to premenstrual dysphoric disorder (PMDD). Participants must be practicing in France for at least two years and fluent in French. No interventions are involved; the goal is to describe current awareness and management approaches and identify gaps that could inform occupational health policies. The lead site is the University Hospital Strasbourg, with coordination through the Strasbourg psychiatry service. Results could guide future training and resource development for PMDD in occupational health settings.
Why it matters
Potential benefit: Findings may help improve awareness and management of PMDD among occupational health professionals, potentially benefiting affected workers.
How similar studies have gone: Prior work in medical education and occupational health has used surveys to describe knowledge and practices; this study applies a similar approach to PMDD and occupational health in France.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Occupational physicians or occupational health collaborators * Practicing in France for at least two years * Agreeing to participate in the study Exclusion Criteria: * Lack of proficiency in the French language
Where it's running
-
Service de Psychiatrie 2 - CHU de Strasbourg - France
Strasbourg, France Recruiting
Study contacts
- Study coordinator: Sébastien WEIBEL, MD, PhD
- Email: sebastien.weibel@chru-strasbourg.fr
- Phone: 33 3 88 11 51 57
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Do PMDD patients have a different mid-luteal hormone balance than people without PMDD?
This study tests whether people with PMDD have different mid-luteal levels of progesterone and estradiol, and their ratio, compared with healthy controls.
-
Epigenetic markers linked to PMDD across the menstrual cycle
This study tests whether blood epigenetic markers can tell apart women with PMDD from women without PMDD at different points in the menstrual cycle.
-
Investigating hormone effects on premenstrual dysphoric disorder
This study is trying to see how certain hormones and a low-dose antidepressant can affect women with premenstrual dysphoric disorder compared to those without it.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.